​Emma Heckenberg, Ph.D., is an analyst at Solas BioVentures, where she applies scientific rigor and commercial judgment to identify, analyze, and support high-potential healthcare

companies. She earned her Ph.D. in Molecular Genetics and Microbiology from Duke University, studying how viral infections affect pediatric populations, and her B.S. in Biology with a minor in Business from Drexel University. Drawing on this cross-disciplinary training, she aims to blend mechanistic innovation and real-world need into an investable thesis by backing teams that building durable, high-impact solutions for patients.​